14 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Stemline Competitors or Alternatives

Stemline's top competitors include Agenus, Agios and Blueprint.

Unlock 20 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Stemline's company profile

Ivan Bergstein

President & CEO

90/100
100 - 250
$48.3M
$25M - 100M
  • $48.3M
    $25M - 100M
  • 100 - 250
    $48.3M
  • $25M - 100M
  • 90/100
  • 100 - 250
  • $48.3M
  • $25M - 100M
View ProfileView
1
Stemline's Competitor - Agenus logo

Garo H. Armen

Chairman & CEO

85/100
440
$352.2M
$103.5M
  • $352.2M
    $103.5M
  • 440
    $352.2M
  • $103.5M
  • 85/100
  • 440
  • $352.2M
  • $103.5M
View ProfileView
2
Stemline's Competitor - Agios logo

Brian Goff

CEO

85/100
390
$226M
$36.5M
  • $226M
    $36.5M
  • 390
    $226M
  • $36.5M
  • 85/100
  • 390
  • $226M
  • $36.5M
View ProfileView
3
Stemline's Competitor - Blueprint logo

Kate Haviland

CEO

82/100
640
$2.2B
$508.8M
  • $2.2B
    $508.8M
  • 640
    $2.2B
  • $508.8M
  • 82/100
  • 640
  • $2.2B
  • $508.8M
View ProfileView
4
Stemline's Competitor - Verastem Oncology logo

Dan Paterson

President & CEO

82/100
50
$531.7M
$10M
  • $531.7M
    $10M
  • 50
    $531.7M
  • $10M
  • 82/100
  • 50
  • $531.7M
  • $10M
View ProfileView
5
Stemline's Competitor - BioGenex logo

Krishan L Kalra

Chairman & CEO

86/100
250 - 500
- -
$25M - 100M
  • - -
    $25M - 100M
  • 250 - 500
    - -
  • $25M - 100M
  • 86/100
  • 250 - 500
  • - -
  • $25M - 100M
View ProfileView
Stemline's top 23 competitors are Agenus, Agios, Blueprint, OncoMed Pharmaceuticals, Verastem Oncology, BioGenex, Tarveda, AVEO, TG Therapeutics, Biodesix, CytomX, MEI Pharma, Genentech, Nanosphere, Pharmacyclics, Spinifex Pharmaceuticals Pty. Ltd., Entelos, Boston Biomedical, Neumedicines, Polaris, Crown Bioscience, Centrose and Juno Therapeutics. Together they have raised over 9.4B between their estimated 19.4K employees. Stemline's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 1.2B. Stemline has 100 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 811.

Stemline VS Agenus

Agenus is one of Stemline's top rivals. Agenus was founded in Lexington, Massachusetts} in 1994. Like Stemline, Agenus also competes in the Biotechnology space. Compared to Stemline, Agenus generates $56.5M more revenue.

Stemline VS Agios

Agios is Stemline's #2 competitor. Agios was founded in 2008, and is headquartered in Cambridge, Massachusetts. Like Stemline, Agios also operates in the Pharmaceuticals space. Agios generates $10.5M less revenue vs. Stemline.

Stemline VS Blueprint

Blueprint is a top competitor of Stemline. Blueprint's headquarters is in Cambridge, Massachusetts, and was founded in 2011. Like Stemline, Blueprint also works within the Biotechnology sector. Blueprint generates 1,082% of Stemline's revenue.

Looking for similar companies to Stemline?

Similar Companies

Pharmaceuticals companies in New York

See 562 companies 
Pharmaceuticals companies with employees in 100-250 range

See 815 companies 
Biotechnology companies in New York

See 660 companies 
Pharmaceuticals companies with revenue in $25-100M range

See 828 companies 
Biotechnology companies in New York Metropolitan Area

See 859 companies 
Biotechnology companies with revenue in $25-100M range

See 862 companies 
Pharmaceuticals companies in New York Metropolitan Area

See 1,035 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Pharmaceuticals & Biotechnology companies in New York

See 1,119 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Stemline and Stemline's Competitors

April 23, 2025centralcharts
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced three upcoming presentations at the 2025 American Society of Clinical Oncology...
April 25, 2025Citybizlist
BOSTON-(BUSINESS WIRE)-Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pa...
April 25, 2025Zacks
On the Q1 2025 earnings call, investors can expect updates regarding the progress in the development of CTMX's lead candidate, CX-2051, for colorectal ...
April 24, 2025PMLiVE
The collaboration will leverage Repertoire's immune mapping DECODE platform...
April 23, 2025StreetInsider
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Drop...
April 23, 2025Seeking Alpha
April 25, 2025FinanzNachrichten
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY), announced that the New England Journal of Medicine has published a deta...
April 23, 2025Endpoints News
A Bay Area protein design startup wants to build more potent antibody-drug conjugates, and is starting with $20 million in seed funding. The company, S...
April 23, 2025BioSpace
Roche's Genentech is betting on the Flagship Pioneering-founded company's discovery platform called DECODE to find new targets for an undisclosed autoi...
April 23, 2025Endpoints News
Every few years, Repertoire Immune Medicines makes a major announcement in April. And this year is no different. The Flagship Pioneering-incubated star...

Frequently Asked Questions about Stemline

  1. Who are Stemline's top competitors?

    Stemline's top 3 competitors are Agenus, Agios, Blueprint.

  2. Who is similar to Stemline?

    Agenus is the most similar to Stemline. Agios and Blueprint are also similar to Stemline.

  1. Are Stemline and Agenus competitors?

    Yes, Agenus is one of Stemline’s top competitors.